MQS Management’s CureVac CVAC Stock Holding History

MQS Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-16,176	Closed	-$220K	–	449
2022 Q2	$220K	Buy	+16,176	New	+$268K	0.15%	299

Other funds holding CVAC

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MQS Management's CVAC Position: Q3 2022 in Review

MQS Management sold out of CureVac (CVAC) in Q3 2022, closing a stake of 16,176 shares — an estimated $220K sold.

MQS Management first reported a position in CVAC in Q2 2022 and held it in 1 quarter. The position peaked at $220K in Q2 2022. 83 funds tracked by Wall St. Rank hold CVAC as of Q3 2022.

MQS Management reported no remaining CureVac position as of Q3 2022 after selling out during the quarter.
MQS Management sold 16,176 CureVac shares in Q3 2022, an estimated $220K.
MQS Management first reported a position in CureVac in Q2 2022 and held it in 1 quarter.
MQS Management's CureVac position peaked at $220K in Q2 2022.
83 funds tracked by Wall St. Rank held CureVac as of Q3 2022.

Based on MQS Management's 13F filing for Q3 2022, filed 9 Nov 2022.